Liver gene disruptions: Winners by KO?

Journal of Hepatology

Volumn 31, Issue 4, 1999, Pages 752-759

  Smith, Alexander J ^a,b   Ronald, P J ^a   Elferink, Oude ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b A ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CHOLESTEROL; SCATTER FACTOR;

CHOLESTEROL METABOLISM; GENE DISRUPTION; KNOCKOUT GENE; KNOCKOUT MOUSE; LIVER DEVELOPMENT; LIVER DISEASE; LIVER METABOLISM; LIVER REGENERATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0344549304     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80359-6     Document Type: Editorial

References (77)

1. Hooper M, Hardy K, Handyside A, Hunter S, Monk M. Hprtdeficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature. 326:1987;292-295.
2. Mansour SL, Thomas KR, Capecchi MR. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature. 336:1988;348-352.
3. Bradley A. Production and analysis of chimaeric mice. Robertson EJ. Teratocarcinomas and Embryonic Stem Cell: A Practical Approach. 1987;113-152 IRL Press, Oxford.
4. Hilberg F, Aguzzi A, Howells N, Wagner EF. C-jun is essential for normal mouse development and hepatogenesis. Nature. 365:1993;179-181.
5. Angel P, Allegretto EA, Okino ST, Hattori K, Boyle WJ, Hunter T, et al. Oncogene jun encodes a sequence-specific trans-activator similar to ap-1. Nature. 332:1988;166-171.
6. Hirai SI, Ryseck RP, Mechta F, Bravo R, Yaniv M. Characterization of jund: a new member of the jun proto-oncogene family. EMBO J. 8:1989;1433-1439.
7. Lamph WW, Wamsley P, Sassone-Corsi P, Verma IM. Induction of proto-oncogene jun/ap-1 by serum and tpa. Nature. 334:1988;629-631.
8. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the rel A component of nf-kappa b. Nature. 376:1995;167-170.
9. Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature. 376:1995;768-771.
10. Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M, et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature. 373:1995;699-702.
11. Ganiatsas S, Kwee L, Fujiwara Y, Perkins A, Ikeda T, Labow MA, et al. SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc Natl Acad Sci USA. 95:1998;6881-6886.
12. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Ann Rev Immunol. 12:1994;141-179.
13. Stein B, Baldwin AS Jr., Ballard DW, Greene WC, Angel P, Herrlich P. Cross-coupling of the NF-kappa B p65 and fos/jun transcription factors produces potentiated biological function. EMBO J. 12:1993;3879-3891.
14. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 251:1991;802-804.
15. Defrances MC, Wolf HK, Michalopoulos GK, Zarnegar R. The presence of hepatocyte growth factor in the developing rat. Development. 116:1992;387-395.
16. Uehara Y, Minowa O, Mori C, Shiota K, Kuno J, Noda T, et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature. 373:1995;702-705.
17. Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, et al. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-jun. Nature. 372:1994;794-798.
18. Yan M, Dai T, Deak JC, Kyriakis JM, Zon LI, Woodgett JR, et al. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature. 372:1994;798-800.
19. Rodrigues GA, Park M, Schlessinger J. Activation of the jnk pathway is essential for transformation by the met oncogene. EMBO J. 16:1997;2634-2645.
20. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, et al. The stress-activated protein kinase subfamily of c-jun kinases. Nature. 369:1994;156-160.
21. Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, Genin A, et al. Mutations in the human jagged1 gene are responsible for Alagille syndrome. Nat Genet. 16:1997;235-242.
22. Taub R. Liver regeneration 4: transcriptional control of liver regeneration. FASEB J. 10:1996;413-427.
23. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 274:1996;1379-1383.
24. Cressman DE, Diamond RH, Taub R. Rapid activation of the stat3 transcription complex in liver regeneration. Hepatology. 21:1995;1443-1449.
25. Trautwein C, Rakemann T, Niehof M, Rose-John S, Manns MP. Acute-phase response factor, increased binding, and target gene transcription during liver regeneration. Gastroenterology. 110:1996;1854-1862.
26. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type 1 tumor necrosis factor receptor. Proc Nat Acad Sci USA. 94:1997;1441-1446.
27. Diehl AM, Yin M, Fleckenstein J, Yang SQ, Lin HZ, Brenner DA, et al. Tumor necrosis factor-alpha induces c-jun during the regenerative response to liver injury. Am J Physiol. 267:(Pt 1):1994;G552-G561.
28. Yamada Y, Fausto N. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am J Pathol. 152:1998;1577-1589.
29. Sakamoto T, Liu Z, Murase N, Ezure T, Yokomuro S, Poli V, et al. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology. 29:1999;403-411.
30. Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, Hammer RE, et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor Lxr alpha. Cell. 93:1998;693-704.
31. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signalling pathway mediated by the nuclear receptor lxr alpha. Nature. 383:1996;728-731.
32. Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, et al. Activation of the nuclear receptor Lxr by oxysterols defines a new hormone response pathway. J Biol Chem. 272:1997;3137-3140.
33. Russell DW, Setchell KD. Bile acid biosynthesis. Biochemistry. 31:1992;4737-4749.
34. Schwarz M, Lund EG, Setchell KDR, Kayden HJ, Zerwekh JE, Bjorkhem I, et al. Disruption of cholesterol 7alpha-hydroxylase gene in mice. ii. Bile acid deficiency is overcome by induction of oxysterol 7alpha-hydroxylase. J Biol Chem. 271:1996;18024-18031.
35. Schwarz M, Lund EG, Lathe R, Bjorkhem I, Russell DW. Identification and characterization of a mouse oxysterol 7alpha-hydroxylase cDNA. J Biol Chem. 272:1997;23995-24001.
36. Schwarz M, Russell DW, Dietschy JM, Turley SD. Marked reduction in bile acid synthesis in cholesterol 7alpha-hydroxylase-deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia. J Lipid Res. 39:1998;1833-1843.
37. Rosen H, Reshef A, Maeda N, Lippoldt A, Shpizen S, Triger L, et al. Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J Biol Chem. 273:1998;14805-14812.
38. Cali JJ, Hsieh CL, Francke U, Russell DW. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem. 266:1991;7779-7783.
39. Leitersdorf E, Reshef A, Meiner V, Levitzki R, Schwartz SP, Dann EJ, et al. Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews of Moroccan origin. J Clin Invest. 91:1993;2488-2496.
40. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
41. Mahley RW, Innerarity TL. Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta. 737:1983;197-222.
42. van Ree JH, van den Broek WJAA, Dahlmans VEH, Groot PHE, Vidgeon-Hart M, Frants RR, et al. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. Atherosclerosis. 111:1994;25-37.
43. Kuipers F, van Ree JH, Hofker MH, Wolters H, In't Veld G, Havinga R, et al. Altered lipid metabolism in apolipoprotein Edeficient mice does not affect cholesterol balance across the liver. Hepatology. 24:1996;241-247.
44. Goldstein JL, Brown MS. Familial hypercholesterolemia. Scriver CR, Beaudet AL, Sly WS, Valle D. The Metabolic Basis of Inherited Diseases. 1989;1215-1250 McGraw-Hill Inc. New York.
45. Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest. 93:1994;1885-1893.
46. Herz J, Qiu SQ, Oesterle A, DeSilva HV, Shafi S, Havel RJ. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc Nat Acad Sci USA. 92:1995;4611-4615.
47. Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Stanley KK. Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 7:1988;4119-4127.
48. Rohlmann A, Gotthardt M, Hammer RE, Herz J. Inducible inactivation of hepatic lrp gene by cre-mediated recombination confirms role of lrp in clearance of chylomicron remnants. J Clin Invest. 101:1998;689-695.
49. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, van Deemter L, et al. Homozygous disruption of the murine mdr2 p-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell. 75:1993;451-462.
50. Gros P, Ben Neriah YB, Croop JM, Housman DE. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature. 323:1986;728-731.
51. Gros P, Croop J, Housman D. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell. 47:1986;371-380.
52. Coleman R, Rahman K. Lipid flow in bile formation. Biochim Biophys Acta. 1125:1992;113-133.
53. Mauad TH, van Nieuwkerk CM, Dingemans KP, Smit JJM, Schinkel AH, Notenboom RG, et al. Mice with homozygous disruption of the mdr2 p-glycoprotein gene. a novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol. 145:1994;1237-1245.
54. Deleuze JF, Jacquemin E, Dubuisson C, Cresteil D, Dumont M, Erlinger S, et al. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology. 23:1996;904-908.
55. de Vree JM, Jacquemin E, Sturm E, Cresteil D, Bosma PJ, Aten J, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA. 95:1998;282-287.
56. Kazama Y, Hamamoto T, Foster DC, Kisiel W. Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. J Biol Chem. 270:1995;66-72.
57. Torres-Rosado A, O'Shea KS, Tsuji A, Chou SH, Kurachi K. Hepsin, a putative cell-surface serine protease, is required for mammalian cell growth. Proc Natl Acad Sci USA. 90:1993;7181-7185.
58. Wu Q, Yu D, Post J, Halks-Miller M, Sadler JE, Morser J. Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease. J Clin Invest. 101:1998;321-326.
59. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, Kimura S, et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding ah receptor. Science. 268:1995;722-726.
60. Flodby P, Barlow C, Kylefjord H, Ahrlund-Richter L, Xanthopoulos KG. Increased hepatic cell proliferation and lung abnormalities in mice deficient in ccaat/enhancer binding protein alpha. J Biol Chem. 271:1996;24753-24760.
61. Soriano HE, Kang DC, Finegold MJ, Hicks MJ, Wang ND, Harrison W, et al. Lack of c/ebp alpha gene expression results in increased DNA synthesis and an increased frequency of immortalization of freshly isolated mice hepatocytes. Hepatology. 27:1998;392-401.
62. Lee SS, Buters JT, Pineau T, Fernandez-Salguero P, Gonzalez FJ. Role of cyp2el in the hepatotoxicity of acetaminophen. J Biol Chem. 271:1996;12063-12067.
63. Fan CY, Pan J, Usuda N, Yeldandi AV, Rao MS, Reddy JK. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-coa oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism. J Biol Chem. 273:1998;15639-15645.
64. Hentsch B, Lyons I, Li R, Hartley L, Lints TJ, Adams JM, et al. Hlx homeo box gene is essential for an inductive tissue interaction that drives expansion of embryonic liver and gut. Genes Devel. 10:1996;70-79.
65. Tagawa Y, Sekikawa K, Iwakura Y. Suppression of concanavalin A-induced hepatitis in IFN-gamma (-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol. 159:1997;1418-1428.
66. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, et al. Immune response in mice that lack the interferon-gamma receptor. Science. 259:1993;1742-1745.
67. Loranger A, Duclos S, Grenier A, Price J, Wilson-Heiner M, Baribault H, et al. Simple epithelium keratins are required for maintenance of hepatocyte integrity. Am J Pathol. 151:1997;1673-1683.
68. Herz J, Clouthier DE, Hammer RE. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell. 71:1992;411-421.
69. Du H, Duanmu M, Witte D, Grabowski GA. Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage. Hum Mol Genet. 7:1998;1347-1354.
70. Smit JW, Schinkel AH, Muller M, Weert B, Meijer DK. Contribution of the murine mdr1a p-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an mdrla gene disruption. Hepatology. 27:1998;1056-1063.
71. Liu J, Liu Y, Habeebu SS, Klaassen CD. Metallothionein (mt)-null mice are sensitive to cisplatin-induced hepatotoxicity. Toxicol Appl Pharmacol. 149:1998;24-31.
72. Gunes C, Heuchel R, Georgiev O, Muller KH, Lichtlen P, Bluthmann H, et al. Embryonic lethality and liver degeneration in mice lacking the metal-responsive transcriptional activator mtf-1. EMBO J. 17:1998;2846-2854.
73. Baes M, Gressens P, Baumgart E, Carmeliet P, Casteels M, Fransen M, et al. A mouse model for Zellweger syndrome. Nat Genet. 17:1997;49-57.
74. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, et al. Requirement of stat5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA. 94:1997;7239-7244.
75. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
76. Williams AO, Knapton AD, Geiser A, Letterio JJ, Roberts AB. The liver in transforming growth factor-beta-1 (TGF-beta 1) null mutant mice. Ultrastruct Pathol. 20:1996;477-490.
77. Diehl AM, Rai RM. Liver regeneration 3: regulation of signal transduction during liver regeneration. FASEB J. 10:1996;215-227.